FDA daily

FDA daily for Monday, September 21, 2026

In this issue: 18 approvals, 9 device recalls and 32 label changes. 1 item touches categories MedGrid carries, and it comes first.

For MedGrid's categories

Items in this issue that name a product category sold on MedGrid. Each links to its full FDA record; the chip opens that category's federal and state rules.

Drug and biologic approvals

FDA date:

On Mon, Sep 14 FDA approved 5 new applications (1 brand or biologic, 4 generic) and 13 supplements to existing ones.

  • BEXLUTRY

    CURIUM · LUTETIUM LU 177 DONATATE

    NDA218525Drug (NDA)Prescription
  • LETROZOLE

    ZYDUS LIFESCIENCES · LETROZOLE

    ANDA220438Generic (ANDA)Prescription
  • BECLOMETHASONE DIPROPIONATE

    AUROLIFE PHARMA LLC · BECLOMETHASONE DIPROPIONATE

    ANDA214418Generic (ANDA)Prescription
  • HALOPERIDOL

    AJANTA PHARMA LTD · HALOPERIDOL

    ANDA218210Generic (ANDA)Prescription
  • EPINEPHRINE

    ZYDUS PHARMS · EPINEPHRINE

    ANDA219832Generic (ANDA)Prescription
Browse drug and biologic approvals in FDA data →

Device recalls

FDA date:

FDA posted 9 device recalls from 3 firms on Mon, Sep 14.

Browse device recalls in FDA data →

Label updates

FDA date:

32 drug labels took effect on Mon, Sep 7; 1 of the 25 read for this issue is for products in MedGrid's categories. Below: those, and labels carrying a boxed warning.

Browse label updates in FDA data →

FDA did not answer for Clearances, Drug recalls, Food and supplement recalls, Drug shortages while this issue was written; those sections will fill in on a later visit.

How the FDA daily is written

Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.

Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.

Read FDA's day. Stock your practice.

Join free with your NPI: wholesale pricing from verified vendors, with the FDA and state rules for each category one click away.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.